Sommaire

• • ·A glance into the Book of Abstracts – Second International Congress on Neuropathic Pain

    Page :vii

    Ralf Baron

     
• • ·1 THE ROLE OF POTASSIUM AND OTHER CHANNELS IN THE PATHOPHYSIOLOGY AND TREATMENT OF NEUROPATHIC PAIN

    Page :1

    A.H. Dickenson

    
• • ·2 EVIDENCE-BASED MEDICAL TREATMENT OF NEUROPATHIC PAIN

    Page :1-2

    S.H. Sindrup

    
• • ·3 EVIDENCE-BASED ASSESSMENT OF INTERVENTIONAL TREATMENTS FOR NEUROPATHIC PAIN

    Page :2

    H.J. McQuay

    
• • ·4 COMBINATION DRUG THERAPY FOR NEUROPATHIC PAIN

    Page :2

    I. Gilron

    
• • ·5 NEUROPATHIC PAIN AND INFLAMMATION: AN ANIMAL MODEL OF POST-HERPETIC NEURALGIA

    Page :2-3

    S.M. Fleetwood-Walker

    
• • ·6 TOWARDS PREVENTION OF POSTHERPETIC NEURALGIA

    Page :3

    R.W. Johnson

    
• • ·7 PAIN IN HIV-ASSOCIATED NEUROPATHY

    Page :3-4

    D.M. Simpson

    
• • ·8 DESCENDING CONTROL OF NEUROPATHIC PAIN: INHIBITORY OR FACILITATORY?

    Page :4

    M.H. Ossipov

    
• • ·9 THE PLACEBO EFFECT: FROM MECHANISMS TO CLINICAL IMPLICATIONS

    Page :4-5

    F. Benedetti

    
• • ·10 FUNCTIONAL IMAGING IN NEUROPATHIC PAIN

    Page :5

    I. Tracey

    
• • ·11 PLASTICITY OF INHIBITION THROUGH MICROGLIA TO NEURON SIGNALLING

    Page :5

    M.W. Salter

    
• • ·12 Workshop Summary: BRAIN EVOKED POTENTIALS AS A TOOL TO DIAGNOSE NEUROPATHIC PAIN

    Page :6

    G. Iannetti

    
• • ·13 LASER-EVOKED POTENTIALS IN PERIPHERAL NEUROPATHY

    Page :6

    U. Baumgärtner

    
• • ·14 DIAGNOSTIC ROLE OF LASER EVOKED POTENTIALS IN CENTRAL NEUROPATHIC PAIN

    Page :6-7

    L. Garcia-Larrea

    
• • ·15 BRAIN POTENTIALS EVOKED BY MECHANICAL STIMULI: A NEW TOOL FOR ASSESSING CENTRAL SENSITISATION?

    Page :7

    G.D. Iannetti

    
• • ·16 Workshop Summary: NEUROPATHIC PAIN – DEFINITION AND SCREENING

    Page :7

    T.S. Jensen

    
• • ·17 NEUROPATHIC PAIN QUESTIONNAIRES: COULD THEY BE USED IN CLINICAL RESEARCH?

    Page :7-8

    D. Bouhassira

    
• • ·18 NEW SCREENING TOOLS FOR NEUROPATHIC PAIN: ARE THEY USEFUL FOR DAILY CLINICAL ROUTINE?

    Page :8

    R. Freynhagen

    
• • ·19 NEUROPATHIC PAIN: DEFINITION AND SCREENING

    Page :8

    T.S. Jensen

    
• • ·20 Workshop Summary: ECTOPIC DISCHARGES IN C-NOCICEPTORS AS A CAUSE OF NEUROPATHIC PAIN

    Page :8-9

    J. Serra

    
• • ·21 ECTOPIC DISCHARGES IN C-NOCICEPTORS AS A CAUSE OF NEUROPATHIC PAIN

    Page :9

    J. Serra

    
• • ·22 ERYTHROMELALGIA AS A HUMAN MODEL OF C-FIBER HYPEREXCITABILITY

    Page :9-10

    S.G. Waxman

    
• • ·23 CELLULAR PROCESSES ASSOCIATED WITH ECTOPIA

    Page :10

    M. Devor

    
• • ·24 Workshop Summary: HUMAN SURROGATE MODELS OF NEUROPATHIC PAIN: AN OBLIGATORY INTERMEDIARY OF TRANSLATIONAL RESEARCH

    Page :10-11

    T. Klein

    
• • ·25 HUMAN SURROGATE MODELS OF PAIN MEMORY: IMPLICATIONS FOR MECHANISMS OF CENTRAL SENSITIZATION AND RELATED TREATMENT OPTIONS IN NEUROPATHIC PAIN PATIENTS

    Page :11

    T. Klein

    
• • ·26 SURROGATE MODELS: ADVANTAGES AND LIMITATIONS EXEMPLIFIED BY THE SYMPTOM OF COLD INDUCED PAIN

    Page :11

    G. Wasner

    
• • ·27 TRANSLATIONAL MEDICINE APPROACHES IN DEVELOPMENT OF NOVEL NEUROPATHIC PAIN TREATMENTS

    Page :11-12

    B.A. Chizh

    
• • ·28 Workshop Summary: INVESTIGATION OF CENTRAL PAIN MECHANISMS IN HUMANS

    Page :12

    N. Attal

    
• • ·29 MECHANISMS OF SPINAL CORD INJURY PAIN – EVIDENCE FROM HUMAN STUDIES

    Page :12-13

    N. Finnerup

    
• • ·30 FUNCTIONAL IMAGING OF ALLODYNIA IN NEUROPATHIC PAIN

    Page :13

    R. Peyron, I. Faillenot, L. Garcia-Larrea, B. Laurent

    
• • ·31 ROLE OF THALAMUS IN CENTRAL PAIN – A REVIEW OF FINDINGS FROM PATIENTS

    Page :13

    J. Dostrovsky

    
• • ·32 Workshop Summary: DEVELOPING CLINICALLY USEFUL CANNABINOID ANALGESICS

    Page :13-14

    A.S.C. Rice

    
• • ·33 CANNABIS CONCERNS AND CAUTIONS

    Page :14

    S. Lawrie

    
• • ·34 Workshop Summary: QUANTITATIVE SENSORY TESTING IN RESEARCH AND CLINICAL TRIALS

    Page :14

    R. Baron

    
• • ·35 QUANTITATIVE SENSORY TESTING IN RESEARCH

    Page :14-15

    R. Baron

    
• • ·36 QUANTITATIVE SENSATION TESTING IN RESEARCH AND CLINICAL PRACTICE

    Page :15

    P.J. Dyck

    
• • ·37 QST IN CLINICAL TRIALS – POTENTIALS AND CHALLENGES

    Page :15

    M. Backonja

    
• • ·38 Workshop Summary: NEUPSIG GUIDELINES ON CLASSIFICATION, ASSESSMENT AND TREATMENT OF NEUROPATHIC PAIN

    Page :15-16

    R.-D. Treede

    
• • ·39 CONSENSUS STATEMENT ON REDEFINITION OF NEUROPATHIC PAIN AND A PROPOSAL FOR A GRADING SYSTEM

    Page :16

    R.-D. Treede

    
• • ·40 WHAT IS EXPECTED FROM GENERAL PRACTITIONERS IN THE DIAGNOSIS AND TREATMENT OF NEUROPATHIC PAIN?

    Page :16-17

    M. Haanpää

    
• • ·41 GUIDELINES FROM THE NEUPSIG TREATMENT COMMITTEE

    Page :17

    R.H. Dworkin

    
• • ·42 Workshop Summary: MAPK ACTIVATION IN NEUROPATHIC PAIN

    Page :17

    G.R. Strichartz

    
• • ·43 ROLES OF EXTRACELLULAR SIGNAL-REGULATED PROTEIN KINASES (ERK) 5 IN SPINAL MICROGLIA AND PRIMARY SENSORY NEURONS FOR NEUROPATHIC PAIN

    Page :17-18

    K. Noguchi, K. Obata

    
• • ·44 ACTIVATION OF C-JUN N-TERMINAL KINASE (JNK) IN SPINAL ASTROCYTES FOR THE MAINTENANCE OF NEUROPATHIC PAIN

    Page :18

    R.-R. Ji, I. Decosterd

    
• • ·45 ENDOTHELIN-A AND -B RECEPTORS ACTIVATE ERK IN DORSAL HORN NEURONS

    Page :18-19

    G. Strichartz, F. Yanagidate

    
• • ·46 PHOSPHORYLATION OF SODIUM CHANNEL NAV1.8 BY P38 MAPK INCREASES CURRENT DENSITY IN DRG NEURONS

    Page :19

    A. Hudmon, J. Choi, L. Tyrrell, J.A. Black, A.M. Rush, S.G. Waxman, S.D. Dib-Hajj

    
• • ·47 Workshop Summary: COLD PAIN – FROM SKIN TO BRAIN

    Page :19

    A. Binder

    
• • ·48 THE MOLECULAR BASIS OF COLD SENSATION AND COLD PAIN

    Page :19-20

    D.D. McKemy

    
• • ·49 TOWARDS SURROGATE MODELS OF COLD HYPERALGESIA

    Page :20

    N. Attal

    
• • ·50 BRAIN MECHANISMS OF COLD-PAIN AND COLD HYPERALGESIA

    Page :20

    A. Binder

    
• • ·51 Workshop Summary: PHANTOM LIMB PAIN – MECHANISMS AND THERAPY

    Page :21

    R. Melzack

    
• • ·52 NEURAL MECHANISMS OF PHANTOM LIMB PAIN

    Page :21

    M. Devor

    
• • ·53 TREATMENT OF PHANTOM LIMB PAIN

    Page :21

    R.W. Johnson

    
• • ·54 CENTRAL MECHANISMS OF PHANTOM PAIN: TREATMENT IMPLICATIONS

    Page :21-22

    H. Flor

    
• • ·55 Workshop Summary: SPINAL CORD TREATMENT FOR NEUROPATHIC PAIN: WHERE IS THE EVIDENCE?

    Page :22

    G. Varrassi, F. Marinangeli

    
• • ·56 EFNS GUIDELINES ON SPINAL CORD STIMULATION FOR NEUROPATHIC PAIN

    Page :22

    G. Cruccu, B.A. Simpson, R.S. Taylor

    
• • ·57 A CLINICIAN’S PERSPECTIVE ON INTERVENTIONAL PAIN MANAGEMENT IN NEUP: WHAT ACTUALLY WORKS?

    Page :23

    J.-P. Van Buyten

    
• • ·58 INFLUENCES OF DORSAL ROOT GANGLION PULSED RADIOFREQUENCY ON SPINAL CORD

    Page :23

    J. Van Zundert, B. Joosten, J. Patijn, M. Van Kleef

    
• • ·59 Workshop Summary: NEUROIMAGING AS A DIAGNOSTIC TOOL FOR NEUROPATHIC PAIN: FACT OR FANTASY?

    Page :23-24

    T.R. Tölle

    
• • ·60 WHAT TO LEARN FROM LIGAND-PET IMAGING STUDIES?

    Page :24

    T.R. Tölle, M. Valet, G. Henriksen, T. Sprenger

    
• • ·61 FUNCTIONAL MRI AS A TOOL FOR DIAGNOSIS IN NEUROPATHIC PAIN

    Page :24

    I. Tracey, P. Schweinhardt, H. McQuay, K. Wartolowska

    
• • ·62 WHAT CAN BRAIN MORPHOMETRY TELL US ABOUT CHRONIC PAIN?

    Page :24-25

    M.C. Bushnell, A. Kuchinad, P. Schweinhardt, D.A. Seminowicz

    
• • ·63 Workshop Summary: ASSESSMENT AND TREATMENT OF NEUROPATHIC BACK PAIN

    Page :25

    R. Rolke

    
• • ·64 QUESTIONNAIRES IN NEUROPATHIC PAIN: WHAT HAVE WE LEARNED FROM THE LANSS PAIN SCALE?

    Page :25-26

    M.I. Bennett

    
• • ·65 QUANTITATIVE SENSORY TESTING: ASSESSMENT OF THE NEUROPATHIC COMPONENT IN LOW BACK PAIN

    Page :26

    R. Rolke

    
• • ·66 TREATMENT OF NEUROPATHIC PAIN: INTERVENTIONAL TREATMENT OPTIONS

    Page :26-27

    S. Erdine

    
• • ·67 Workshop Summary: TRANSIENT RECEPTOR POTENTIAL CHANNELS – AN UPDATE

    Page :27

    K. Noguchi

    
• • ·68 THERMOSENSITIVE TRP CHANNELS AND NOCICEPTION

    Page :27-28

    M. Tominaga

    
• • ·69 SENSITIVITY AND SENSITIZATION OF PERIPHERAL NERVE AXONS INVOLVE THE CAPSAICIN RECEPTOR TRPV1

    Page :28

    P.W. Reeh

    
• • ·70 COLD-SENSITIVITY OF SENSORY NEURONS

    Page :28

    M. Koltzenburg

    
• • ·71 Workshop Summary: SMALL FIBER NEUROPATHY – FROM BASIC SCIENCE TO THE CLINIC

    Page :28-29

    C. Sommer

    
• • ·72 LABORATORY MODELS OF NEUROPATHIC PAIN AND THEIR APPLICATION IN DEVELOPING NEW ANALGESICS

    Page :29

    S.M. Fleetwood-Walker, C.J. Proudfoot, E.M. Garry, D.F. Cottrell, R. Rosie, H. Anderson, A. Delaney, D.C. Robertson, R. Mitchell

    
• • ·73 CUTANEOUS INNERVATION IN SMALL FIBER NEUROPATHIES

    Page :29

    J.W. Griffin

    
• • ·74 PAIN IN SMALL FIBER NEUROPATHIES: SKIN BIOPSY FINDINGS AND MEASURES OF INFLAMMATION

    Page :29-30

    C. Sommer, E. Vlckova, W. Kafke, N. Ueceyler

    
• • ·75 Workshop Summary: CRPS – A DISEASE WITH MANY FACES

    Page :30-31

    S.N. Raja

    
• • ·76 EXTENDED DIAGNOSTIC PROCEDURES IN PATIENTS WITH COMPLEX REGIONAL PAIN SYNDROME

    Page :31

    C. Maier

    
• • ·77 COMPLEX REGIONAL PAIN SYNDROME: NO BRAIN – NO PAIN?

    Page :31

    C. Maihofner

    
• • ·78 CRPS – A DISEASE WITH LIMITED EVIDENCE-BASED THERAPIES

    Page :31-32

    S.N. Raja

    
• • ·79 Workshop Summary: EPIDURAL STEROIDS FOR SCIATICA, AND QUALITY OF LIFE

    Page :32

    J.C.D. Wells

    
• • ·80 NERVE BLOCKS FOR CHRONIC PAIN – WHAT IS THE EVIDENCE?

    Page :32-33

    S.H. Butler

    
• • ·81 EPIDURAL STEROIDS FOR BACK PAIN AND SCIATICA – HOW ARE THEY DONE AND DO THEY WORK?

    Page :33-34

    J.C.D. Wells

    
• • ·82 Workshop Summary: ASSESSMENT OF OUTCOMES IN NEUROPATHIC PAIN CONDITIONS AND PRE-CLINICAL MODELS. ARE WE LOOKING AT THE SAME THING?

    Page :34

    P.T. Hansson

    
• • ·83 Workshop Summary: RESULTS OF AN AAN/EFNS TASK FORCE ON TRIGEMINAL NEURALGIA MANAGEMENT

    Page :34-35

    T.J. Nurmikko

    
• • ·84 AAN/EFNS GUIDELINES ON DIAGNOSIS OF TRIGEMINAL NEURALGIA

    Page :35

    G. Cruccu, G. Gronseth

    
• • ·85 GUIDELINES FOR SURGICAL TREATMENT FOR TRIGEMINAL NEURALGIA

    Page :35

    J.M. Zakrzewska

    
• • ·86 AAN/EFNS GUIDELINES FOR PHARMACOTHERAPY OF TRIGEMINAL NEURALGIA

    Page :35-36

    T.J. Nurmikko

    
• • ·87 Workshop Summary: GROWTH FACTORS AND HYPERALGESIA

    Page :36

    S.B. McMahon

    
• • ·88 SYNAPTIC SECRETION AND LOCAL ACTIONS OF NEUROTROPHINS

    Page :36

    V. Lessmann

    
• • ·89 THE ROLE OF BDNF IN MICROGLIA-NEURON SIGNALLING AFTER PERIPHERAL NERVE INJURY

    Page :36-37

    M.W. Salter

    
• • ·90 CCL2 AS A MEDIATOR OF NEUROPATHIC PAIN STATES

    Page :37

    S.B. McMahon

    
• • ·91 Workshop Summary: CHEMOTHERAPY INDUCED NEUROPATHY

    Page :37

    R. Maag

    
• • ·92 CHEMOTHERAPY INDUCED NEUROPATHY

    Page :37-38

    J. Levine

    
• • ·93 Workshop Summary: RECENT DEVELOPMENTS IN HERPES ZOSTER AND POSTHERPETIC NEURALGIA: MECHANISMS, PREVENTION AND TREATMENT

    Page :38

    M. Haanpää

    
• • ·94 MECHANISM-BASED TREATMENT OF HERPES ZOSTER AND POSTHERPETIC NEURALGIA

    Page :38

    M. Haanpää

    
• • ·95 ZOSTER VACCINE FOR THE PREVENTION OF POSTHERPETIC NEURALGIA

    Page :38-39

    M.N. Oxman

    
• • ·96 INVASIVE TREATMENT OF HERPES ZOSTER AND POSTHERPETIC NEURALGIA

    Page :39

    A.J.M. van Wijck

    
• • ·97 Workshop Summary: TOPICAL AND TRANSDERMAL TREATMENTS FOR NEUROPATHIC PAIN

    Page :39-40

    G. Gourlay

    
• • ·98 HIGH-CONCENTRATION CAPSAICIN FOR TREATMENT OF PHN AND HIV NEUROPATHY PAIN

    Page :40

    M. Backonja

    
• • ·99 TOPICAL LIDOCAINE AND CAPSAICIN: DOES THE NEUROPATHIC PAIN NEEDS A SECOND SKIN?

    Page :40

    G. Wasner

    
• • ·100 TOPICAL AND PERIPHERALLY ACTING ANALGESICS FOR NEUROPATHIC PAIN MANAGEMENT

    Page :40-41

    E. Alon, M. Jaquenod-Linder, C. Wanner Schmid

    
• • ·101 Workshop Summary: ANXIETY, DEPRESSION AND QUALITY OF LIFE IN NEUROPATHIC PAIN

    Page :41

    P. Murphy

    
• • ·102 THE ROLE OF PSYCHOSOCIAL FACTORS AND NEUROPATHIC PAIN

    Page :41

    J. Haythornthwaite

    
• • ·103 ASSESSMENT OF PSYCHOSOCIAL FACTORS IN NEUROPATHIC PAIN

    Page :41

    H.M. Poole

    
• • ·104 TREATMENT FOR NEUROPATHIC PAIN FROM A PSYCHOSOCIAL PERSPECTIVE

    Page :41-42

    P. Murphy

    
• • ·105 EPIDEMIOLOGY OF DIABETIC NEUROPATHY IN MEXICO

    Page :42

    M. Genis Rondero

    
• • ·106 EPIDEMIOLOGY OF PAINFUL DIABETIC NEUROPATHY IN CENTRAL AMERICA AND THE CARIBBEAN

    Page :42

    E. Ibarra

    
• • ·107 EPIDEMIOLOGY OF DIABETES NEUROPATHY IN SOUTH AMERICA

    Page :42-43

    M.J. Gutfrajnd

    
• • ·108 Workshop Summary: MOLECULAR AND SYNAPTIC MECHANISMS FOR NEUROPATHIC PAIN

    Page :43

    M. Zhuo

    
• • ·109 MOLECULAR MECHANISMS FOR MODIFICATION OF SYNAPTIC TRANSMISSION OF AFFERENTS FOLLOWING PERIPHERAL NERVE INJURY

    Page :43-44

    X. Zhang

    
• • ·110 ANALOGY OF A-BETA AFFERENTS TERMINATION IN PATHOLOGICAL CONDITIONS WITH IMMATURE STATE

    Page :44

    M. Yoshimura, T. Nakatsuka, H. Furue

    
• • ·111 ENHANCED PRESYNAPTIC AND POSTSYNAPTIC EXCITATORY TRANSMISSION IN THE ACC AFTER NERVE INJURY

    Page :44

    M. Zhuo

    
• • ·112 Workshop Summary: DOPAMINERGIC MECHANISMS OF PAIN CONTROL

    Page :44-45

    A.I. Basbaum, W. Magerl

    
• • ·113 MODULATION OF PAIN BY THE STRIATUM, A POTENTIAL CULPRIT IN RLS

    Page :45

    A. Pertovaara

    
• • ·114 NEUROPATHIC PAIN IN RESTLESS LEGS SYNDROME – A DISORDER OF PAIN CONTROL

    Page :45

    K. Stiasny-Kolster, W. Magerl, W.H. Oertel, R.-D. Treede

    
• • ·115 Workshop Summary: RECENT ADVANCES IN INVESTIGATION AND MANAGEMENT OF HEADACHE AND MIGRAINE

    Page :46

    J.E. Charlton

    
• • ·116 MIGRAINE

    Page :46

    A.J. Dowson

    
• • ·117 WHAT HAVE WE LEARNED FROM NEUROIMAGING IN HEADACHE?

    Page :46

    A. May

    
• • ·118 CALCITONIN GENE-RELATED PEPTIDE (CGRP) INVOLVEMENT IN MIGRAINE

    Page :46-47

    J. Olesen

    
• • ·119 Workshop Summary: OPIOIDS FOR CHRONIC NON-CANCER PAIN

    Page :47

    M. Zenz

    
• • ·120 OPIOIDS FOR NON-MALIGNANT PAIN – ARE OPIOIDS BETTER THAN ALTERNATIVES?

    Page :47

    H.J. McQuay

    
• • ·121 CHRONIC NON-CANCER PAIN PREDOMINANTLY NEUROPATHIC AND THE LONG TERM SAFETY AND EFFICACY OF OPIOIDS

    Page :47-48

    C.P.N Watson

    
• • ·122 PRESCRIBING OPIOIDS FOR CHRONIC PAIN: A RATIONAL APPROACH

    Page :48

    S.N. Raja

    
• • ·123 THE EVOLUTION OF CHRONIC PAIN – POTENTIAL TARGETS FOR PREVENTION

    Page :48

    C.J. Woolf

    
• • ·124 CAN WE IDENTIFY PATIENTS WHO NEED PREVENTIVE THERAPY?

    Page :49

    T.S. Jensen

    
• • ·125 PREVENTION OF CHRONIC POST-SURGICAL PAIN – CLINICAL TRIALS CONSIDERATIONS

    Page :49-50

    H. Kehlet

    
• • ·126 LACOSAMIDE: A NEW ANTICONVULSANT FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY

    Page :50

    C. Sommer, D. Ziegler

    
• • ·127 LOCALIZED APPROACHES TO THE MANAGEMENT OF NEUROPATHIC PAIN SYNDROMES: PHYSIOLOGIC RATIONALE AND CLINICAL RESULTS

    Page :50-52

    M. Wallace, M. Backonja

    
• • ·128 THE PROCESS STUDY – RCT OF NEUROSTIMULATION THERAPY VERSUS CONVENTIONAL MEDICAL MANAGEMENT IN NEUROPATHIC BACK AND LEG PAIN

    Page :52

    S. Eldabe

    
• • ·129 SPINAL CORD STIMULATION IN DRUG REFRACTORY NEUROPATHIC PAIN: WHERE ARE WE AND WHERE ARE WE GOING?

    Page :52-53

    P.T. Hansson

    
• • ·130 CLINICAL EXPERIENCE WITH NEUROSTIMULATION THERAPY – WHICH PATIENTS WHEN?

    Page :53

    J.-P. Van Buyten

    
• • ·131 CHAIRMAN’S INTRODUCTION: TOPICAL LIDOCAINE – A NOVEL STANDARD TREATMENT FOR NEUROPATHIC PAIN

    Page :53-54

    R. Baron

    
• • ·132 VERSATIS^®: PRACTICAL AND PHARMACO-DYNAMIC BENEFITS OF TOPICAL THERAPY

    Page :53-54

    G. Hans

    
• • ·133 TOPICAL LIDOCAINE – EXPERIMENTAL MODELS OF NEUROPATHIC PAIN AND IMPLICATIONS FOR SYMPTOMATIC TREATMENT

    Page :55

    B. Gustorff

    
• • ·134 EFFICACY AGAINST TYPICAL SYMPTOMS OF NEUROPATHIC PAIN – CLINICAL EVIDENCE ON VERSATIS

    Page :55-56

    S. Schug

    
• • ·135 TOPICAL LIDOCAINE – ITS PLACE IN TREATMENT ALGORITHMS AND CLINICAL PRACTICE

    Page :56-57

    J.C.D. Wells

    
• • ·136 Gabapentin and pregabalin suppress mechano-cold allodynia in the spared nerve injury (SNI) model of neuropathic pain

    Page :59

    S. Oerther, K. Ängeby Möller, V. Tapp, H. Gustafsson

    
• • ·137 Antinociceptive effect of botulinum toxin type A in experimental diabetic neuropathy

    Page :59-60

    L. Bach-Rojecky, M. Salkovic-Petrisic, Z Lackovic

    
• • ·138 Spinal cord excitement: Descending pathways that modulate dorsal horn excitability in pathophysiological states

    Page :60

    L.A. Bee, A.H. Dickenson

    
• • ·139 Capsaicin avoidance following chorda tympani transection

    Page :60

    E. Carstens, M. Iodi Carstens, Y. Boucher

    
• • ·140 Efficacy of tapentadol, a novel centrally acting analgesic with dual mode of action, in animal models of chronic neuropathic pain

    Page :61

    T. Christoph, M. Meen, J. De Vry, T.M. Tzschentke

    
• • ·141 Botulinum neurotoxins: New frontiers in neuropathic pain therapy?

    Page :61

    S. Cobianchi, S. Marinelli, S. Luvisetto, F. Pavone

    
• • ·142 Chronic post-ischemia pain: A novel animal model suggests that ischemia–reperfusion (I–R) injury, no-reflow and chronic tissue ischemia contribute to CRPS-I

    Page :61-62

    A. Laferriere, M. Millecamps, D.N. Xanthos, W. Xiao, G.J. Bennett, T.J. Coderre

    
• • ·143 Vanilloid receptor 1-positive neurons mediate neuropathic pain

    Page :62

    J.G. Cui, G. Tender, Y.Y. Li, N.G. Bazan

    
• • ·144 The automated electronic Von Frey filaments constitutes a suitable method to evaluate mechanical allodynia in experimental animals

    Page :62-63

    E. Del Pozo, J.M Entrena, J.M. Baeyens

    
• • ·145 Spontaneous pain behaviour is related to spontaneous firing frequency in uninjured nociceptive c-fibre neurons after spinal nerve axotomy

    Page :63

    L. Djouhri, S. Koutsikou, S.N. Lawson

    
• • ·146 Murine models of neuropathic pain

    Page :63

    X. Fang, H.-F. Wei, D.R. Collins, F.-Y. Zhao

    
• • ·147 Opioids in animal models of neuropathic pain

    Page :63-64

    M.D. Ferrer, X. Santiveri, P. Ariño, A. Montes, F. Escolano, M.M. Puig

    
• • ·148 Catwalk analysis and pain research: Gait parameters as a measure of inflammatory pain in the acute but not chronic phase

    Page :64

    A.F. Gabriel, W.M. Honig, M.A. Marcus, E.A. Joosten

    
• • ·149 Response properties of nociceptive neurons in the amygdala of the neuropathic rat

    Page :64-65

    L. Goncalves, O.B. Ansah, A. Almeida, A. Pertovaara

    
• • ·150 Tramadol attenuates hyperalgesia, activation of NF-κ B and production of proinflammatory cytokines in rat model of neuropathic pain

    Page :65

    P. Hassanzadeh

    
• • ·151 Mononeuropathic animals displayed depressive-like behaviour in the model of forced swimming test

    Page :65-66

    B. Hu, H. Doods, A. Kremer, K. Roeska, R.D. Treede, A. Ceci

    
• • ·152 Experimental manipulations that influence the development of mechano-cold allodynia in the spared nerve injury (SNI) model

    Page :66

    K. Hygge-Blakeman, S. Oerther

    
• • ·153 NADPH-d and c-Fos immunoreactive neurons in the rat brain stem following peripheral nerve injury

    Page :66

    S. Jergova, D. Kolesar, D. Cizkova

    
• • ·154 Sucrose loading decreases thermal pain sensitivity, evaluated with tail-flick test in diabetic (OLETF), but not in non-diabetic (LETO) rats

    Page :66-67

    Z.A. Kamenov, H. Higashino, M.K. Todorova, N. Aoki, M. Imamura, V.G. Christov

    
• • ·155 The effect of nitric oxide on mechanical and thermal allodynia in neuropathic pain model of rat

    Page :67

    S.H. Kim, S.J. Jung

    
• • ·156 Modification of bursting activities in somatosensory cortex in inflamed-rats in vivo

    Page :67-68

    K. Koga, H. Shiokawa, M. Mizuno, A. Doi, H. Takase/Mizuguchi, H. Furue, M. Yoshimura

    
• • ·157 Lacosamide, an investigational analgesic, does not show potential for abuse liability or dependence in preclinical tests

    Page :68

    N. Krebsfaenger, T. Stoehr

    
• • ·158 Cold sensitivity is increased in spinal dorsal horn wide dynamic range (WDR) neurons in spared nerve injury (SNI) rats

    Page :68-69

    L. Luo, H. Gustafsson, K. Hygge Blakeman, K. Angeby-Moller, O.-G. Berge

    
• • ·159 Differences between inflammatory responses in dorsal root ganglia and spinal cord after chronic constriction or transection of rat sciatic nerve

    Page :69

    P. Hu, A.L. Bembrick, K.A. Keay, E.M. McLachlan

    
• • ·160 A rat model for cancer pain in the trigemina nerve area

    Page :69

    S. Nagahata, N. Harano, K. Ono, Y. Seta, S. Shiiba, O. Nakanishi

    
• • ·161 Attenuation of formalin-induced nociceptive behaviors following oral administration of gabapentin and pregabalin

    Page :69-70

    S. Oerther, V. Tapp, H. Gustafsson

    
• • ·162 Influence of diet on temporal development of tactile allodynia and opioid hyposensitivity for 22-weeks in the Zucker diabetic fatty rat

    Page :70

    K.J. Otto, B.D. Wyse, S.M. South, P.J. Cabot, M.T. Smith

    
• • ·163 TRO19622 targets mitochondria and reverses pain in animal models of neuropathic pain

    Page :70-71

    R.M. Pruss, B. Buisson, V. Cuvier, J.-L. Abitbol, F. Marchand, J. Grist, M. Malcangio, T. Bordet

    
• • ·164 Anxiety-like behaviour is observed in two rat models of mononeuropathy

    Page :71

    K. Roeska, H. Doods, B. Hu, A. Kremer, R.D. Treede, A. Ceci

    
• • ·165 Spine deformation in rat models of neuropathic pain can cause pain related behavior

    Page :71

    V. Kosta, S. Lovric-Kojundzic, L. Cambj-Sapunar, D. Sapunar

    
• • ·166 Pregabalin supraspinally activates the descending noradrenergic pain inhibitory system after peripheral nerve injury

    Page :72

    M. Tanabe, Y. Takeuchi, K. Takasu, H. Ono

    
• • ·167 Spinal cord stimulation in a mouse chronic neuropathic pain model

    Page :72

    M. Truin, Y. Verboeket, W. Honig, R. Deumens, M. van Kleef, E.A. Joosten

    
• • ·168 Susceptibility to nerve injury-induced hypersensitivity and responsiveness to SCS in DA, PVG, and PVG-RT1AV1 rats

    Page :72-73

    C. Ultenius, A. Josephson, Z.Y. Song, B.A. Meyerson, B. Linderoth, O. Lidman

    
• • ·169 Oral administration of stavudine induces mechanical hyperalgesia and increased CINC-1 in the spinal cord of rats

    Page :73

    J. Weber, D. Mitchell, B. Mitchell, P.R. Kamerman

    
• • ·170 Nociceptive responses to vasoactive agents in an animal model of CRPS-I

    Page :73-74

    D.N. Xanthos, T.J. Coderre

    
• • ·171 A chronic compression model of trigeminal neuralgia

    Page :74

    D.C. Yeomans, J.M. Cuellar, M. Klyukinov, N. Manering, S.R. Levinson

     
• • ·172 Comparing local delivery of ketorolac and pentoxifylline in the Chung and Bennett rat models of neuropathic pain

    Page :74-75

    J.M. Zanella, K. Hildebrand, E. Burright, B. McKay, T.L. Yaksh

     
• • ·173 Localized treatment with NGX-4010 significantly reduced pain for up to 12 weeks: A randomized, double blind controlled study in postherpetic neuralgia

    Page :75-76

    M.M. Backonja, M.S. Wallace, J. Tobias, M. Elhamy

    
• • ·174 Coadministration of gabapentin with lamotrigine in neuropathic pain therapy: Can it improve therapeutic compliance?

    Page :76

    B. Battista, D. Da Prato, D. Tammaro, M. Pennimpede, A. Aperto, M. Calderone, R. Palomba

    
• • ·175 A comparison of TCA (amitriptyline/nortriptyline) and venlafaxine in the treatment of chronic non-cancer pain

    Page :76-77

    H.K. Bendixen, A. Bendiksen, G. Handberg

    
• • ·176 Pharmacological comparison of the combined μ-opioid receptor agonist and monoamine reuptake inhibitor NS7051 with tramadol in animal experimental pain models

    Page :77

    G. Blackburn-Munro, H.K. Erichsen, E.O. Nielsen, D. Peters

    
• • ·177 A multi-center, open-label, follow-on trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy

    Page :77-78

    R. Bodenschatz, M. Bretschneider, S. Thierfelder, S. Bongardt

    
• • ·178 Intravenous immunoglobulins treatment improves pain in diabetic lumbosacral radiculoplexus neuropathy

    Page :78

    S. Tamburin, A. Forgione, C. Cacciatori, D. Idone, G. Zanette

    
• • ·179 Buprenorphine patch in non-malignant low back pain: Our experience

    Page :78-79

    C. Di Maria, V. Palmieri, L. Di Lorenzo, A.M. Forte, C. Trombetti, E. De Blasio

    
• • ·180 A different analgesic ladder for neuropathic pain?

    Page :79

    R. Galvez, S. Ruiz, J. Romero

    
• • ·181 Methadone in management of intractable neuropathic pain

    Page :79

    E.Y. Cardona, A.A. Kassian

    
• • ·182 Intradermal administration of botulinum toxin, type A, is effective in treating neuropathic pain disorders

    Page :79-80

    W.R. Knoderer, J.C. Krusz

    
• • ·183 Effectiveness of IV therapy for pain in the clinic

    Page :80

    J.C. Krusz, J. Cagle, J. Belanger, V. Scott-Krusz

    
• • ·184 The topical use of amitriptiline and lidocaine for the treatment of chronic neuropathic pain

    Page :80

    T.Y. Lin, M.J. Teixeira, T.R. Zakka, A.M. Maia, M.F. Murari, L. Dardin

    
• • ·185 Transdermal bupivacaine for neuropathic pain: Clinical development progress

    Page :80-81

    D. Lissin, J. Shah, M. Drass, J. Johnston, A. Miksztal, S. Yum

    
• • ·186 Multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of lenalidomide in the treatment of chronic painful radiculopathy

    Page :81

    D. Levinsky, S. Gupta, M. Byas-Smith, M. Hale, J. Gimble, A. Cooper, E. Kurkimilis, J. Zeldis, D. Manning

    
• • ·187 Treatment of neuropathic pain in CRPS type-I on a polypharmacological basis

    Page :81-82

    A. Moesker

    
• • ·188 Prospective study of the pharmacologic management of chronic neuropathic non-cancer pain

    Page :82

    D.E. Moulin, P.K. Morley-Forster, B. Connolly, J. Guerin, A.J. Clark

    
• • ·189 Oral prolonged release (PR) oxycodone/naloxone combination reduces opioid-induced bowel dysfunction (OIBD) in patients with severe chronic pain

    Page :82

    S. Müller-Lissner, P. Leyendecker, M. Hopp, C. Ruckes, W. Fleischer, K. Reimer

    
• • ·190 Neurophatic pain in romania: A pharmacoepidemiologic approach

    Page :82-83

    O.C. Mungiu, L. Tartau

    
• • ·191 Association of buprenorphine TDS and pregabalin in the treatment of low back pain

    Page :83

    V. Pota, M. Maisto, M.C. Pace, M. Iannotti, E.G. Ruggiero, E. Galdo, M.B. Passavanti, C. Aurilio

    
• • ·192 Efficacy and tolerability of oxicodone for treating neuropathic pain

    Page :83-84

    M. Sanjuan Alvarez, P. Molano Diaz, L. Gutierrez Garcia

    
• • ·193 Hyoscine-n-butyl bromide failed to prevent tolerance development to the antinociceptive effect of pilocarpine

    Page :84

    Z. Sezer, G. Sezer, Y. Tekol

    
• • ·194 Fentanyl buccal tablet (FBT) in the treatment of breakthrough pain in opioid-tolerant patients with chronic neuropathic pain: randomized, placebo-controlled study

    Page :84

    D.M. Simpson, F. Xie, J. Messina

    
• • ·195 Lacosamide demonstrates no potential for QTc-prolongation

    Page :84-85

    D. Thomas, J. Zisowsky, R. Horstmann

    
• • ·196 Low potential for drug–drug-interaction of lacosamide

    Page :85

    D. Thomas, U. Scharfenecker, B. Nickel, P. Doty, W. Cawello, R. Horstmann

    
• • ·197 Application of lidocaine patches 5%: How many patches need to be applied on a daily base in routine clinical practice?

    Page :85-86

    K. Van Maldeghem, P. Bruyneel, K. Deseure, D. Robert, G. Hans

    
• • ·198 Laser evoked potentials in carpal tunnel syndrome

    Page :86

    M. De Tommaso, G. Libro, M. Sardaro, C. Serpino, C. Pecoraro, O. Difruscolo, B. Passarella, P. Livrea

    
• • ·199 Persistent idiopathic facial pain (PIFP): The role of neurophysiological (NFS) evaluation

    Page :86-87

    E. Gastaldo, G. Devigili, R. Quatrale, E. Sette, M.C. Sensi, M.R. Tola, E. Granieri, V. Tugnoli

    
• • ·200 Test/retest- and interobserver-reliabilitiy in quantitative sensory testing according to the protocol of the german network on neuropathic pain (DFNS)

    Page :87

    C. Geber, T. Klein, R. Rolke, W. Magerl, M. Dieterich, F. Birklein, R.-D. Treede

    
• • ·201 Differentiation of pain patterns in low back pain of pregnancy with quantitative sensory testing

    Page :87-88

    B. Gustorff, A. Huber, D. Mayr

    
• • ·202 Comparison of quantitative sensory testing and laser-evoked brain potentials in syringomyelia patients

    Page :88

    S.M. Hatem, N. Attal, M. Gautron, L. Plaghki, D. Bouhassira

    
• • ·203 Assessment of neuropathic pain patients in a family practice setting using DN4 questionnaire and quantitative sensory testing

    Page :88-89

    A. Hum, H. Tick, G.D. Ko

    
• • ·204 Pinprick-evoked potentials (PEPS): A novel tool to assess central sensitisation in humans

    Page :89

    G.D. Iannetti, U. Baumgärtner, M.C. Lee, I. Tracey, W. Magerl, R.-D. Treede

    
• • ·205 Neuropathic pain in the population of outpatient elderly

    Page :89

    L.B. Jovanovic

    
• • ·206 Anxiety, depression and alcohol abuse in patients of general practitioners and GP-based pain resource

    Page :90

    T. Kauppila, M. Vuorilehto, A. Sutela, A.M. Nieminen

    
• • ·207 Significant wind-up-ratio in patients with depression in comparison to patients with fibromyalgia and rheumatic arthritis

    Page :90

    S. Klauenberg, A. Hoffmann, G. Juckel, E.K. Krumova, H. Richter, A. Scherens, C. Maier

    
• • ·208 How response inhibition modulates nociceptive laser evoked brain potentials

    Page :90-91

    S.M. Hatem, L. Plaghki, A. Mouraux

    
• • ·209 Sensitivity and concurrent validity of the neuropathic pain impact on quality of life scale

    Page :91

    H.M. Poole, P. Murphy, T.J. Nurmikko

    
• • ·210 Measuring vasomotor disturbances in patients with a cold intolerance after nerve injury

    Page :91-92

    S. Niehof, F. Zijlstra, F.J.P.M. Huygen

     
• • ·211 Cognitive-behavioural strategies during the first year of spinal cord injury neuropathic pain

    Page :92-93

    S. Hulebes Alonso, J. Taylor, C. Penacoba, F. Calderon Munoz, J.R. Cabrera Feria, H. Poole

    
• • ·212 Mechanism-based classification of neuropathic facial pain – use of cluster analysis with quantitative sensory testing data

    Page :93

    C. Rolko, D. Rasche, C. Farrugia, H.H. Capelle, J.K. Krauss, V. Tronnier, H. Flor

    
• • ·213 Classification of low back related leg pain: A study protocol

    Page :93-94

    A. Schafer, T. Hall, K. Briffa

    
• • ·214 Neuropathic components of acute whiplash pain

    Page :94

    M.M. Sterling

    
• • ·215 Extramedian and proximal spread of sensory symptoms in carpal tunnel syndrome: A clinical–neurophysiological study

    Page :94

    S. Tamburin, S. Marani, G. Zanette

    
• • ·216 Impact of spinal cord injury physical factors on neuropathic pain and quality of life during the first year of lesion

    Page :94-95

    S. Huelbes Alonso, A. Mauderli, A. Rivera Lopez, H. Poole, F. Calderon Munoz, J.R. Cabrera Feria, C. Shaw Fernandez-Toda, J. Taylor

    
• • ·217 Differential coding of cold allodynia a FMRI study

    Page :95

    A. Binder, R. Maag, M. Peller, G. Wasner, H. Siebner, R. Baron

    
• • ·218 Operculo-insular and mid-cingulate gyrus functional coupling after painful laser stimulation: An intra-cerebral EEG coherence study

    Page :95-96

    M. Frot, H. Vioux, L. Garcia-Larrea

    
• • ·219 Emotional modulation of pain: Is it the sensation or what we recall?

    Page :96-97

    F. Godinho, M. Magnin, M. Frot, C. Perchet, L. Garcia-Larrea

     
• • ·220 μ-Opioid receptor binding potential in the forebrain correlates with pain modulation in healthy subjects

    Page :97

    N. Hagelberg, I.K. Martikainen, S. Aalto, K. Nagren, U. Pesonen, J. Hietala, H. Scheinin, A. Pertovaara

    
• • ·221 Structural changes associated with pain in spinal cord injured patients

    Page :97-98

    P.J. Wrigley, S.M. Gustin, P.G. Nash, V.G. Macefield, S.C. Gandevia, J.W. Middleton, P.J. Siddall, L.A. Henderson

    
• • ·222 The supraspinal representation of central sensitization in humans

    Page :98

    M.C. Lee, L. Zambraneau, G.D. Iannetti, D.K. Menon, I. Tracey

    
• • ·223 Cortical mechanisms for the relief of phantom limb pain by means of mental imagery: An FMRI study

    Page :98

    K.M. MacIver, D.M. Lloyd, S.C. Kelly, N. Roberts, T.J. Nurmikko

    
• • ·224 Differential influence of brain 5-HT1A receptors on pain versus touch

    Page :98-99

    I.K. Martikainen, J Hirvonen, N. Hagelberg, U. Pesonen, J. Kajander, K. Nagren, J. Hietala, A. Pertovaara

    
• • ·225 Electrophysiological correlates of the cortical interactions and integration of nociceptive and non-nociceptive somatosensory afferents in humans

    Page :99

    A. Mouraux, L. Plaghki

    
• • ·226 A feasibility study of EEG and fMRI co-activation with CHEPS (contact heat evoked potential stimulator)

    Page :99-100

    K. Roberts, A. Papadaki, C. Conçalves, M. Tighe, D. Atherton, R. Shenoy, D. McRobbie, P. Anand

    
• • ·227 Acupuncture as a additional therapy in postherpetic neuralgia – Preliminary study

    Page :98

    K. Brzezinski, M. Jarosz

    
• • ·228 Are there any specific psychopathological features in patients with reflex sympathetic dystrophy?

    Page :100-101

    D. Castelain Devillers, M.C. Defontaine Catteau, S.M. Catsaros, B. Veys, A. Bera Louville, S. Blond

    
• • ·229 Asymmetric sympathetic autonomic responses to ambiguous visual stimulation in complex regional pain syndrome (CRPS) type 1 patients

    Page :101

    H.E. Cohen, N. Harris, C.S. McCabe, J. Hall, D.R. Blake

    
• • ·230 Reflex sympathetic dystrophy1 and facticious disorders

    Page :101

    M.C. Defontaine Catteau, A. Bera Louville, D. Castelain Devillers, S.M. Catsaros, B. Veys, E. Delaporte, S. Blond

    
• • ·231 Differential expression patterns of cytokines in CRPS I

    Page :101-102

    N. Üceyler, T. Eberle, T. Schlereth, F. Birklein, C. Sommer

    
• • ·232 Long-term effect of intravenous regional block on skin temperature in complex regional pain syndrome

    Page :102

    M. Fukusaki, M. Takada, K Miura, Y. Terao, K. Sumikawa

    
• • ·233 Improvement of blood flow, pain and function in the cold CRPS by nitric oxide

    Page :102-103

    J.G. Groeneweg, F.J Huygen, S. Niehof, F. Wesseldijk, F.J. Zijlstra

    
• • ·234 Post-herpetic neuralgia and trigeminal neuralgia pain improved with intradermal botulinum Toxin-A

    Page :103

    G.D. Ko, I. Finkelstein

    
• • ·235 Diagnosing complex regional pain syndrome (CRPS) by a comprehensive analysis of long-term skin temperature changes

    Page :103-104

    E.K. Krumova, P. Haußleiter, S. Klauenberg, A. Scherens, C. Maier

    
• • ·236 A case of complex regional pain syndrome resolved by temporary spinal cord stimulation

    Page :104

    K.R. Lee, M.K. Kim, H.S. Lee, S.M. Choi, M.S. Park, B.C. Kim, K.H. Cho

    
• • ·237 Imagined regrowth: Normalising the mental representation of a CRPS arm

    Page :104-105

    J.S Lewis, D.J Peters

    
• • ·238 CRPS and CRPS like disorders involving upper extremity

    Page :105

    K. Margic, J. Pirc

    
• • ·239 Comparison of depression index and quality of life between patients with and without post-herpetic neuralgia

    Page :105-106

    N. Marhx, A. Kassian

    
• • ·240 Post-herpetic neuralgia (PHN) following herpes zoster (HZ): Literature review of European data

    Page :106

    G. Mick, A. Volpi, F. Simon, B. Pedalino

    
• • ·241 Differing attitudes to analgesic options in post-herpetic neuralgia patients: Parallel surveys conducted in 100 patients and 1078 GPs in 2006

    Page :106

    S.H.R. Ratcliffe, E. Hennessy, T. Roycroft, J. Freeman, M. Ba, C. Matijasevic, W.G. Gallagher, R.M. Langford

    
• • ·242 Epidemiology and management costs of herpes zoster (HZ) and post-herpetic neuralgia (PHN) in the UK

    Page :107

    V. Remy, A. Gauthier, M. Martin, B. Pedalino

    
• • ·243 Histamine-iontophoresis for differentiation of C-fibre function in post-herpetic neuralgias

    Page :107

    T.E. Schlereth, A. Schreiber, F. Birklein

    
• • ·244 Prism adaptation to optical deviation alleviates complex regional pain syndrome (CRPS)

    Page :107-108

    M. Sumitani, S. Miyauchi, H. Uematsu, Y. Saitoh, M. Shibata, T. Mashimo

    
• • ·245 High-dose ketamine infusion for complex regional pain syndrome

    Page :108

    J.M. Ramón, G. Tornero-Campello

    
• • ·246 Use of topical capsaicin in the treatment of complex regional pain syndrome

    Page :108-109

    F. Wesseldijk, F.J.P.M. Huygen, F. Zijlstra

    
• • ·247 Lidocain patch 5% reduce postsurgical neuropathic pain with the cancer patients

    Page :109

    G. Abuzarova

    
• • ·248 Methadone in treatment of oncologic neurophatic pain

    Page :109

    D.A. Arbaiza

    
• • ·249 IV Tramadol for treatment of refractory migraines in the clinic

    Page :110

    J. Cagle, D. Cammarata, V. Scott-Krusz, J.C. Krusz

    
• • ·250 Prevalence of neuropathic pain in cancer patients

    Page :110

    J. Canal, M^a.J. Rosauro, A. Pascual, A. Barcelo, A. De Santiago, M.A. Sanchez

    
• • ·251 Sensory profiles in painful vs. non-painful chemotherapy-induced polyneuropathy

    Page :110-111

    C. Geber, C. Egenolf, M. Dieterich, R.-D. Treede, F. Birklein, T. Vogt

    
• • ·252 Tumor necrosis factor alpha contributes to pain and hyperalgesia in a mouse cancer/metastasis model

    Page :111

    C. Constantin, N Mair, C.A. Sailer, H. Blumer, M. Kress

    
• • ·253 Effectiveness of IV lidocaine therapy in the clinic for refractory migraines and headaches

    Page :111-112

    J.C. Krusz, J. Cagle, V. Scott-Krusz, D. Cammarata

    
• • ·254 Generalized somatosensory changes in patients with temporomandibular disorder

    Page :112

    D. Pfau, R. Rolke, M. Daublaender, R.-D. Treede

    
• • ·255 Quantitative sensory testing: Assessment of the neuropathic component in cancer pain

    Page :112-113

    R. Rolke, N. Eich, R. Schwab, J. Jage, M. Weber, R.-D. Treede, M. Dieterich, F. Birklein

    
• • ·256 Comparison of sensory symptoms with nerve conduction study in diabetic patients

    Page :113

    J.Y. An, I.U. Song, J.S. Kim, Y.I. Kim, K.S. Lee, M.S. Park, B.J. Kim

    
• • ·257 A prospective psychophysical study of oxaliplatin and cisplatin induced neurotoxicity in humans

    Page :113-114

    N. Attal, F. Guirimand, M. Gautron, V. Casano, D. Bouhassira

    
• • ·258 A double-blind, randomized, placebo-controlled trial to evaluate time-to-onset of clinically meaningful pain relief in postherpetic neuralgia (PHN) patients treated with pregabalin

    Page :114

    M.C. Rowbotham, B.R. Stacey, K. Phillips, E. Whalen, T.K. Murphy, J.A. Barrett

    
• • ·259 Long-term results of the microsurgical drez-tomy for neuropathic pain due to brachial plexus avulsion : Anatomical learning and clinical discrepancy

    Page :114-115

    E. Blondet, M. Sindou

    
• • ·260 Prevalence of polyneuropathy with or without neuropathic pain in type 1 and 2 diabetic patients

    Page :115

    D. Bouhassira, K. Van Acker, S. Weiss, K. Matthys, C. Mathieu, I. Colin

    
• • ·261 Resolution of ulcers secondary to treatment of painful diabetic peripheral neuropathy (DPN) with the precision spinal cord stimulation (SCS) system

    Page :115

    E. Bowie, D. Kiker, A. Khodavirdi

    
• • ·262 Restless legs syndrome in painful neuropathy is related to nociceptive deafferentation

    Page :115-116

    F. Brindani, F. Vitetta, A. Marbini, F. Gemignani

    
• • ·263 Psychological impact of neuropathic pain

    Page :116

    M.C. Defontaine Catteau, S.M. Catsaros, D. Castelain Devillers, S. Blond

    
• • ·264 Neuropathic itching syndrome: A preliminary study

    Page :116

    G. Devigili, V. Tugnoli, R. Quatrale, I. Casetta, E. Gastaldo, M.R. Tola, G. Lauria, E. Granieri

    
• • ·265 Peripheral nerve axotomy but not tissue inflammation cause increased HCN-1 immunoreactivity in rat DRGs

    Page :117

    L. Djouhri, K. Mott, S. Macrow, L. Gao, S.N. Lawson

    
• • ·266 Sensitization of corneal cold-sensitive nerve terminals following surgical lesion

    Page :117

    T. Donovan-Rodriguez, S. Quirce-Vazquez, A. Parra-Martin, C. Belmonte

    
• • ·267 The effect of a new physical therapy method on diabetic neuropathic pain

    Page :117-118

    M.R. Ebrahimpoor Mashhadi, Z. Liaghat

    
• • ·268 Temporal summation in chronic neuropathic pain patients

    Page :118

    J. Ghoshdastidar, R. Lecybyl, A. Bet, M. Hanna

    
• • ·269 Dipyrone-magnesium, a new alternative to treat neuropathic pain?

    Page :118-119

    J.V. Gomez-Barrios, V. Tortorici

    
• • ·270 Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: A study using the UK and Germany mediplus databases

    Page :119

    M. Gore, A. Sadosky, E. Dukes, K. Tai, D. Leslie, A. Sheehan

    
• • ·271 Systemic and local lidocaine suppresses ectopic spontaneous activity in lesioned A-afferents, but not in C-afferents

    Page :119-120

    N. Gorodetskaya, A. Teliban, L. Grossmann, W. Jaenig

    
• • ·272 Self-administration of a cannabinoid CB2 agonist in an animal model of neuropathic pain

    Page :120

    T. Gutierrez, J.D. Crystal, K.W. Maxwell, A.M. Zvonok, A. Makriyannis, A.G. Hohmann

    
• • ·273 Antiepileptic drugs in pain caused by diabetic neuropathy

    Page :120-121

    A.M. Gutierrez-Alvarez, J.A. Beltran-Rodriguez, C.B. Moreno

     
• • ·274 Behavioural responses and pre-emptive effect of MK-801 and morphine in SNI model in the adult rat

    Page :121

    G.A. Hamidi, H. Manaheji, M. Salami, H. Safakhah

    
• • ·275 Subcostal nerve neuralgia

    Page :121-122

    R. Hertz, T. Elbaz, S. Shue

    
• • ·276 Selective activation of cannabinoid CB2 receptors suppresses chemotherapeutic neuropathy evoked by paclitaxel and vincristine administration

    Page :122

    A.G. Hohmann, E.J. Rahn, K.W. Maxwell, Am. Zvonok, A. Makriyannis

    
• • ·277 Reorganization of DRG neurons following chronic sciatic nerve constriction injury: Correlation with topical morphine and lidocaine analgesia

    Page :122-123

    Y.A. Kolesnikov, A.E. Maaraof, U. Rautinhauser, G.W. Pasternak

    
• • ·278 Intraepidermal nerve fiber density in patients with chemotherapy-induced neuropathy: A prospective study

    Page :123

    A-L. Kautio, M.K. Koskinen, H.K. Haapasalo, P.-L. Kellokumpu-Lehtinen, T.H. Saarto, M.L. Haanpaa

    
• • ·279 Leukocyte-derived opioids produce peripheral antinociception in neuropathic pain

    Page :123

    D. Labuz, Y. Schmidt, A. Schreiter, H.L. Rittner, A. Brack, H. Machelska

    
• • ·280 Drug selection algorithm for long term intrathecal therapy in the management of neuropathic pain

    Page :124

    G. Cerdá-Olmedo, M.L. Franco-Gay, J. Insausti-Valdivia, M.D. López-Alarcón, J.M. López-Millán, S. Moliner-Velazquez, V. Monsalve-Dolz, L.A. Moreno, J. Pérez-Cajaraville, M. Tió-Felip, E. Uriaqrte-Brizuela

    
• • ·281 Characteristic sensory profile in Fabry patients

    Page :124-125

    R. Maag, A. Binder, C. Maier, A. Scherens, T. Toelle, R.D. Treede, R. Baron

    
• • ·282 The cannabinoid agonist win 55,212-2 both reverts and prevents signs of peripheral neuropathy induced by chronic cisplatin in the rat

    Page :125

    M.I. Martin, G. Vera, P.A. Cabezos, M.A. Castillo, R. Abalo

     
• • ·283 Neuropathic pain is attenuated by a viral vector targeting noradrenergic input to the dorsal reticular nucleus

    Page :125-126

    I. Martins, S. Araújo, S.P Wilson, D. Lima, I. Tavares

    
• • ·284 Treatment of pain secondary to diabetic peripheral neuropathy (DPN) with the precision spinal cord stimulation (SCS) system: A case series

    Page :126

    F. McDonnell, A.C. Khodavirdi

    
• • ·285 Abnormalities in small fibre structure and function in female Fabry patients

    Page :126

    A.T. Møller, U. Feldt-Rasmussen, A.K. Rasmussen, S. Kolvraa, F.W. Bach, T.S. Jensen

    
• • ·286 Difference between heat pain and warm perception thresholds in patients with polyneuropathy and healthy individuals

    Page :127

    M. Nebuchennykh, S. Loseth, S.I. Mellgren

    
• • ·287 Vascular and neuroprotective effect of comp-angiopoietin-1 in db/db mice diabetic neuropathy model

    Page :127

    T.S. Park, J.H. Jin, S.J. Jeong, J.H. Park, H.S. Baek, M.H. Pao, S. Lee, W. Kim, J.H. Lee, K.S. Choi

    
• • ·288 The effect of acupressure on phantom pain in client with extremities amputation

    Page :127-128

    Z. Pouresmail, A. Saberi

    
• • ·289 Cannabinoids suppress chemotherapy-evoked painful peripheral neuropathy through spinal sites of action

    Page :128

    E.J. Rahn, A.G. Hohmann

    
• • ·290 Efficacy and safety of pregabalin as treatment of painful diabetic peripheral neuropathy (DPN): A 13-week randomized controlled trial and 6-month safety extension

    Page :128-129

    J. Rosenstock, J.C. Arezzo, L. LaMoreaux, T.K. Murphy, L. Pauer, U. Sharma

    
• • ·291 Expression of peripheral opioid receptors and peptides in a neuropathic pain model

    Page :129

    Y. Schmidt, S.A. Mousa, D. Labuz, H. Machelska

    
• • ·292 T lymphocytes contribute to opioid pain control in neuritis

    Page :129-130

    A. Schreiter, D. Labuz, H.L. Rittner, A. Brack, H. Machelska

    
• • ·293 Spontaneous impulse generation in C-nociceptors of familial erythromelalgia (FE) patients

    Page :130

    O. Uyanik, C. Quiles, H. Bostock, S. Dib-Hajj, T. Fischer, L. Tyrrell, S.G. Waxman, J. Serra

     
• • ·294 The complex rehabilitation in the painful spine syndromes at the old patients

    Page :130-131

    E.L. Sidenco

    
• • ·295 The postmastectomy pain syndrome: An epidemiological study

    Page :131

    O.J. Vilholm, S. Cold, L. Rasmussen, S.H. Sindrup

    
• • ·296 Topographic distribution and postsynaptic responses of nociceptive neurons of the somatosensory cortex during painful stimulation

    Page :131

    T.S. Labakhua, T.T. Tkemaladze, G.P. Gurtskaia, T.K. Janashia, E.V. Abzianidze

    
• • ·297 Involvement of g-protein coupled signaling in the modulation of glial proinflammatory cytokine expression

    Page :132

    S.H. Cho, C.H. Park, J.S. Seo, S.J. Lee, S.B. Oh, K.P. Park, J.S. Kim, S.Y. Choi

    
• • ·298 A bilateral lesion of the insular cortex diminishes neuropathic and inflammatory nociception

    Page :132

    U. Coffeen, A. Lopez-Avila, J.M. Ortega-Legaspi, R. Del Angel, O. Jaimes, F. Pellicer

    
• • ·299 Electrophysiological and anatomical evidence of an oxytocinergic pain control system

    Page :132-133

    M. Condes-Lara, G. Rojas-Piloni, G. Martinez-Lorenzana

    
• • ·300 Increased zif268 response to evoked above-level neuropathic pain following spinal compression injury in rats

    Page :133

    V.S. Densmore, P.B. Osborne, J.R. Keast

    
• • ·301 Does pain measurement distinguish patients with CPSP from patients with typical clinical features but no pain?

    Page :133-134

    R.D. Helme, E. Pitts

    
• • ·302 Structural remodelling of different classes of primary afferents and descending projections in the dorsal horn following spinal cord injury

    Page :134

    A. Kalous, P.B. Osborne, J.R. Keast

    
• • ·303 Pain and pain thresholds in Parkinson’s disease

    Page :134

    S.O. Machnev, O.S. Levin

    
• • ·304 Efficacy, by baseline severity of anxiety symptoms, of pregabalin for treating central neuropathic pain in patients with spinal cord injury (SCI)

    Page :134-135

    T.K. Murphy, P.J. Siddall, T. Griesing

    
• • ·305 The rehabilitation program for the complex regional pain syndrome type I to the haemiplegic patient

    Page :135

    A.S. Nica, A.I. Murgu, G. Mologhianu, M. Ivascu

    
• • ·306 Chronic pain in parkinson’s disease: The cross-sectional dopamip survey

    Page :135-136

    O. Rascol, L. Negre-Pages, D.S.G. DOPAMIP Study Group a

    
• • ·307 Long-term use of sativex in multiple sclerosis central pain; dosing and changes in concomitant analgesia

    Page :136

    D.J. Rog, T.J. Nurmikko, N.S. Sarantis, C.A. Young

    
• • ·308 Pain severity, management and patient functioning in central neuropathic pain: Results from a cross-sectional survey in six European countries

    Page :136-137

    A. Sadosky, E. Dukes

    
• • ·309 Pain detection threshold is decreased in the migraine pre-attack state: Evidence for slight generalized hyperalgesia?

    Page :137

    T. Sand, N. Zhitny, L.J. Stovner

    
• • ·310 The Dejerine Roussy syndrome: The disclosures of Roussy

    Page :137-138

    J.B. Thiebaut, O. Plaisant, J. Mikol, J.F. Uhl, B. Silhouette, H. Andrianasolo, A. Margot-Duclot, L. Sitzmann

    
• • ·311 Motor cortex stimulation for the treatment of different neuropathic pain syndromes

    Page :138

    V.M. Tronnier, D. Klase, D. Rasche

    
• • ·312 Morphine-induced myoclonus in multiple sclerosis patient (case report)

    Page :138

    D. Vondrackova

    
• • ·313 Discomplete lesions of the spinothalamic tract predict the presence of neuropathic pain following spinal cord injury

    Page :138-139

    G. Wasner

    
• • ·314 Case series of multiple sclerosis patients with neuropathic pain improved with the oral cannabinoid nabilone

    Page :139

    W.A. Wine, G.D. Ko, E.J. Tumarkin

    
• • ·315 Movement imagery evokes pain in spinal cord injured patients

    Page :139-140

    S. Gustin, P.J. Wrigley, P.G. Nash, V.G. Macefield, S.C. Gandevia, M.J. Cousins, L.A. Henderson, P.J. Siddall

    
• • ·316 Influence of age on central post-stroke pain

    Page :140

    M. Zaletel, B. Zvan, J. Kobal

    
• • ·317 Chronic pain after open repair of inguinal hernia

    Page :140-141

    M. Kokolaki, A. Bairaktari, P. Kamperi, M. Vafiadou

    
• • ·318 The trigeminal neuralgia: When essential criteria meet compressive etiology

    Page :141

    E. Blondet, T. Briche, D. Vandershooten, V. Prudon, M. Sindou

     
• • ·319 Neuromodulation in the management of pain from brachial plexus avulsion

    Page :141-142

    S. Brill, I. Goor-Aryeh

    
• • ·320 Case report: Efficacy of ziconotide in mixed neuropathic and nociceptive pain

    Page :142

    M. Brookes, S. Eldabe

    
• • ·321 Rapid titration of ziconotide for the treatment of severe intractable back pain from metastatic spinal anaplastic ependymoma

    Page :142-143

    B.M. Bruel, A.W. Burton, J. Ting, M. Mosura

    
• • ·322 Neuropathic chronic pain following traumathic brachial plexus total section managed by transdermal buprenorphine patch(tds): Original case report

    Page :143

    M. Evangelista, B. Cappa

     
• • ·323 Application of spinal chord stimulator in different cases of chronical pain

    Page :143-144

    F. Fossi

    
• • ·324 Rechargeable SCS systems with independent current control benefit patients and the health care system: Case reports

    Page :144

    L. Frank, U. Klostermann, A. Wenk Lang

    
• • ·325 Optimal paresthesia coverage with offset dual parallel leads in spinal cord stimulation for chronic pain

    Page :144-145

    D.S. Goodman, S.L. Page, R.B. Gorman

     
• • ·326 Intravenous administration of adenosine (Adenocor^®) in the treatment of severe, therapy-resistant, central neuropathic pain

    Page :145

    G. Hans, K. Van Maldeghem, D. Robert

    
• • ·327 Case series of fibromyalgia (FMS) patients with neuropathic pain improved with the sublingual cannabinoid sativex

    Page :145-146

    G.D. Ko, W. Wine, E. Tumarkin

    
• • ·328 Successful treatment of leg and lower back pain using a single program with a next generation scs device: Case report

    Page :146

    A. Koulousakis, A.C. Khodavirdi

    
• • ·329 The syndrome of intractable pain of upper limb of a young girl

    Page :146-147

    J. Kozak, I. Vrba, F. Neradilek

    
• • ·330 Diagnosis and treatment of vagal neuralgia in a patient with laryngopharyngeal reflux: A case report

    Page :147

    I. Lokshina, C. Agin, I. Feinstein, R. Katz

    
• • ·331 Madame oui-non: Diagonistic dyspraxia and central pain

    Page :147

    A. Margot-Duclot, J.B. Thiebaut, S. Chokron, B. Silhouette, L. Sitzmann, H. Andrianasolo

    
• • ·332 Nerve sheath catheter analgesia after amputation and phantom pain: A case report in a pediatric patient

    Page :147-148

    L.A. Pereiras

    
• • ·333 Lamotrigine in intractable trigeminal neuralgia associated with multiple sclerosis: A case report

    Page :148

    A. Pražnikar

    
• • ·334 Nicotine and neuropathic pain in spinal cord injury

    Page :148-149

    J.S. Richards, E.J. Richardson, T.J. Ness, C.V. Oleson, B.L. Dinoff, J.F. Roper

     
• • ·335 Case report: Positive clinical experience of treating chronic non-cancer pain with ziconotide

    Page :149

    K.H. Simpson

    
• • ·336 Treatment options in patients affected by persistent vegetative

    Page :149

    N. Stefani, G. Rea, D. Mangeruga, P.V. Nardi

    
• • ·337 The utility of pregabalin in neuropathic pain patients – Degree of benefit in responders and non-responders to gabapentin

    Page :150

    C. Toth

    
• • ·338 Oxycodone in neuropathic pain: A clinical experience

    Page :150

    D. Ventura Vargas, S. Martin Sanchez

    
• • ·339 Case report: Ziconotide treatment for a neuropathic and a degenerative pain problem

    Page :150-151

    A. Ver Donck

    
• • ·340 Numbers, densities and co-localization of AMPA and NMDA receptors at individual synaptic contact areas in the superficial spinal dorsal horn

    Page :151

    M. Antal, Y. Fukozawa, M. Eördögh, R. Shigemoto

    
• • ·341 Neuropathic pain and spinal glia: Characterization of c-jun N-terminal kinase (JNK) activation in astrocyte cultures

    Page :151-152

    A.T. Beggah, A. Parent, M. Pertin, C. Bonny, L. Pellerin, R.R. Ji, I. Decosterd

    
• • ·342 Mapping the signalling pathway of the cannabinoid system in the human brain

    Page :152

    S. Platzer, F. Bonke, A. Buettner, T.R. Toelle, A. Berthele

    
• • ·343 The contribution of TRPA1 and TRPM8 to cold allodynia and neuropathic pain

    Page :152

    O. Caspani, S. Zurborg, P.A. Heppenstall

    
• • ·344 Ralfinamide acts through NMDA receptor complex: A central role for chronic pain treatment

    Page :152-153

    E. Colombo, L. Curatolo, C. Caccia, P. Salvati, L. Faravelli

    
• • ·345 Peripheral effect of cannabinoids: WIN 55,212-2 inhibits axonal activity in the rat skin-nerve in vitro preparation

    Page :153

    R. Giron, C. Goicoechea, N. Paniagua, M.I. Martin

    
• • ·346 Expression of IL-15 in the spinal cord after chronic constriction injury

    Page :154

    D. Gomez-Nicola, E. Martin-Lopez, M. Nieto-Sampedro

     
• • ·347 Induction of filopodial structures by over-expression of TRPV1

    Page :154

    C. Goswami, T. Hucho

    
• • ·348 Excitability after the action potential indicates changes in membrane potential of isolated nociceptive C-fibers

    Page :154-155

    G. Moalem-Taylor, P.M. Lang, D.J. Tracey, P. Grafe

    
• • ·349 Novel dual mechanism of action of the antiepileptic lacosamide

    Page :155

    C. Heers, B. Beyreuther, J. Freitag, G. Lees, A. Errington, T. Stoehr

    
• • ·350 Characterization of endogenous PKC-Epsilon in F11 cell, a model system for studying pain signalling

    Page :155-156

    C. Goswami, J. Kumar, T. Hucho

    
• • ·351 An increased amount of ED-1+ cell profiles in DRG following sciatic nerve ligature and ventral root transection

    Page :156

    P. Dubovy, L. Tuckova, I. Svizenska, R. Jancalek, I. Klusakova

    
• • ·352 Differential changes in TRPV1 expression in trigeminal ganglion neurons following trigeminal sensory nerve injury

    Page :156

    H.Y. Kim, S.J. Jung, J.S. Kim, S.B. Oh

    
• • ·353 Inhibition of COX-2 expression in rat spinal dorsal horn by electroacupuncture in neuropathic pain

    Page :156-157

    W.K. Lau, W.K. Chan, W.T. Chan, J.L. Zhang, H.Q. Zhang

    
• • ·354 The expression of Ca-channel alpha2delta subunit and TRPM8 in dorsal root ganglion of two neuropathic pain rat models

    Page :157

    Y.W. Lee, D.W. Han, T.D. Kweon, J.B. Choi

    
• • ·355 Capsaicin induced cell death in primary cultured neurons

    Page :157

    J.H. Lee, J.H. Cho

    
• • ·356 Eugenol inhibits voltage-gated potassium currents in trigeminal ganglion neurons

    Page :158

    H.Y. Li, C.K. Park, J.S. Kim, S.B. Oh

    
• • ·357 A comparative gene expression study in metabolic and traumatic models of painful peripheral neuropathy

    Page :158

    C. Liberati, C. Gattuso, M. Mattioli, G. De Siena, P. Tarroni

    
• • ·358 Up-regulation of microRNA-16 in the dorsal root ganglion and spinal cord dorsal horn following peripheral nerve injury

    Page :158-159

    R. Kusuda, S. Zanon, T. Amaral E. Souza, F. Cadetti, N. Zanon-Baptista, F.L. De Lucca, G. Lucas

    
• • ·359 Estrogen reduces the heat-activated vanilloid receptor (TRPV1) current in adult female rat nociceptive neurons

    Page :159

    S. Xu, Y. Cheng, J.R. Keast, P.B. Osborne

    
• • ·360 Expression of opioid genes in neuropathic and inflammatory pain

    Page :159-160

    J.R. Parkitna, I. Obara, M. Korostynski, D. Kaminska, W. Makuch, B. Przewlocka, R. Przewlocki

    
• • ·361 Short-term exposure to hypoxic/hyperglycemic conditions is associated with functional changes of TRPV1 currents

    Page :160

    V.P. Ristoiu, M.L. Flonta

    
• • ·362 State-dependent inhibitors of the Nav1.3 sodium channel for treating neuropathic pain

    Page :160

    M. Rogers, L. Tang, R. Davies, J. Wilson, S. Jones, J. Ford, D. Madge

    
• • ·363 Insulin and insulin-like growth factor-I modulate the activity of capsaicin-sensitive cultured dorsal root ganglion neurons

    Page :161

    P. Santha, G. Jancso, I. Nagy

    
• • ·364 T-type calcium current is a molecular determinant of excitatory effects of GABA in adult sensory neurons

    Page :161

    C. Hilaire, H. Aptel, S. Pieraut, J. Valmier, F. Scamps

    
• • ·365 Neuropathic pain levels following surgical nerve injury are controlled by genotypes and haplotypes of COMT – The gene encoding catecholamine-O-methyltransferase

    Page :161-162

    Y. Lu, I. Belfer, E. Gershon, J.-J. Vatine, Y. Shir, T. Jablonski-Peretz, R.M. Pfeffer, H. Hipp, J. Livneh, L. Sun, R. Craiu, D. Goldman, M. Max, Z. Seltzer

    
• • ·366 HTS assay configuration for CGMP-dependent Protein Kinase I-alpha, a possible drug target in pain therapy

    Page :162

    M.C. Sidoli, P. Arioli, L. Redaelli, D. Carettoni

    
• • ·367 Thiamine inhibits hyperexcitability and modulates sodium currents of nociceptive neurons in rats with ganglion compression

    Page :162-163

    X.J. Song, Z.J. Huang, X.S. Song

    
• • ·368 Does the c-Fos activation mediate the expansion of cortical somatosensory fields in phantom pain?

    Page :163-164

    L. Stojiljkovic, S. Glusman, G. Voronov, M. Sekosan, J. Radulovic

     
• • ·369 Two-photon excitation microscopy as a research tool in the analysis of axonal transport in a model of neuropathic pain

    Page :164

    S.R. Van Eck, J.G. Veening, R.F. De Jongh, R.M. Nuydens, J. Van Egmond, K.C. Vissers, T.F. Meert

    
• • ·370 Receptive properties of lamina I spinoparabrachial neurons following a chronic constriction injury

    Page :164-165

    D. Andrew

    
• • ·371 Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat

    Page :165

    O.B. Ansah, H. Leite-Almeida, H. Wei, A. Pertovaara

    
• • ·372 Correlation between pain-related behaviour and spinal microgliosis in distinct models of traumatic, HIV and varicella zoster induced neuropathy

    Page :165-166

    J. Blackbeard, V.C. Wallace, K.P. O’Dea, F. Hasnie, M.J. Field, A.S. Rice

    
• • ·373 Neuropathic pain is decreased in A2A adenosine receptor knockout mice

    Page :166

    S.A. Bura, X. Nadal, C. Ledent, R. Maldonado, O. Valverde

    
• • ·374 Spinal cord changes in rats after immobilisation

    Page :166

    S.H. Butler, M.S. Butler, H. Sharma, T. Gordh

    
• • ·375 Vincristine-induced neuropathic pain in rats: spinal changes of 5HT2A receptor and Fos expression, and microarray analysis

    Page :166-167

    K. Thibault, S. Dubacq, M.J. Brisorgueil, J. Fischer, S. Pezet, B. Calvino, M. Conrath

    
• • ·376 Oligonucleotide IMT504 reduces neuropathic pain after peripheral nerve injury

    Page :167

    M.F. Coronel, A. Hernando-Insua, J. Rodriguez, F. Elias, J. Flo, R. Lopez, N.A. Chasseing, J. Zorzopulos, M.J. Villar, A.D. Montaner

    
• • ·377 Neuropathic pain after adult rat sciatic nerve resection

    Page :167

    R. Deumens, R.J.P. Jaken, M. van Kleef, M.A. Marcus, E.A.J. Joosten

    
• • ·378 Stress-induced analgesia shifts to hyperalgesia in alpha-2A receptor knockout (KO) mice

    Page :167-168

    J.E. Donello, M. Tian, C.V. Cheevers, M. Alcantara, D.W. Gil

    
• • ·379 Dysfunction of meningeal capsaicin-sensitive afferent nerves in a rat model of diabetic neuropathic pain

    Page :168

    M. Dux, J. Rosta, G. Jancso

    
• • ·380 Lacosamide: Overview of the analgesic efficacy in animal models of pain

    Page :168-169

    J. Freitag, B. Beyreuther, T. Stoehr

    
• • ·381 Differential pharmacology of TRPV1 antagonists determines the magnitude of body temperature changes in rats

    Page :169

    S.G. Lehto, R. Tamir, D. Zhu, A. Le, B. Youngblood, D. Immke, M.H. Norman, E. Magal, J.-C. Louis, J.J. Treanor, N.R. Gavva

    
• • ·382 Assessment of neuropathic pain and locomotor deficits using the catwalk gait analysis

    Page :169-170

    R.J.P. Jaken, A.F. Gabriel, G.C. Koopmans, M.A. Marcus, E.A.J. Joosten, R. Deumens

    
• • ·383 Perineural capsaicin and resiniferatoxin induce selective regional analgesia and phenotypic switch of primary sensory neurons expressing TRPV1

    Page :170

    G. Jancsó, P. Santha, O. Oszlacs, T. Nyari

    
• • ·384 Nerve injury triggers glial adaptation in the periaqueductal gray (PAG) of rats with disability and pain, but not pain alone

    Page :170

    K.A. Keay, D. Mor

    
• • ·385 Spontaneous pain following nerve injury is attenuated in the Nav1.8 null mouse

    Page :171

    S. Kelly, S. Pype, S. Lawson

    
• • ·386 Investigation of stress induced analgesia alone or together with CCK receptors agonist and antagonist in neuropathic pain in mice

    Page :171

    A. Mesdaghinia, F. Samiee

    
• • ·387 Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in animal models of neuropathic pain

    Page :171-172

    J. Mika, M. Osikowicz, W. Makuch, B. Przewlocka

    
• • ·388 Diabetic neuropathy is associated to increased neuronal activity at the spinal dorsal horn: A time-course study of c-fos expression

    Page :172

    C. Morgado, I. Tavares

    
• • ·389 Intraperituneal administration of ascorbic acid attenuate hyperalgesia in a rat model of neuropathic pain

    Page :172-173

    F. Nasirinezhad, S. Safarpour

    
• • ·390 A dopamine D2 partial agonist, aripiprazole, diminishes nociception in a neuropathic pain model in the rat

    Page :173

    F. Pellicer, A. Lopez-Avila, U. Coffeen, J.M. Ortega-Legaspi, R. Del Angel, O. Jaimes

    
• • ·391 Effects of the mGluR5 antagonist MPEP and the mGluR7 agonist AMN082 on allodynia, hypersensitivity and morphine analgesia in neuropathic pain

    Page :173

    M. Osikowicz, J. Mika, B. Przewlocka

    
• • ·392 A selective estrogen receptor beta agonist modulates neuropathic and inflammatory pain states

    Page :174

    F. Piu, L. Hyldtoft, L.R. Gardell, C. Cheevers, A.L. DelTredici, C.B. Andersen, L.C. Fairbain, B.W. Lund, M. Gustafsson, D. Gil, D.W. Bonhaus, R. Olsson

    
• • ·393 Synergistic effects between the investigational analgesic lacosamide and other analgesic drugs in the rat formalin test

    Page :174

    J. Freitag, B. Beyreuther, U. Rabus, T. Stoehr

    
• • ·394 Effects of BBB efflux activation on CNS actions of phenobarbital in swiss webster mice

    Page :174-175

    D. Yeomans, W. Robbins, V. Lee

     
• • ·395 Local peripheral antinociceptive effect of venlafaxine on rat formalin test

    Page :175

    G. Sezer, Y. Tekol, Z. Sezer, H. Gul, I.T. Uzbay

    
• • ·396 Downregulation of M4 but not M2 muscarinic receptors in dorsal horn after peripheral nerve injury relates to responsiveness to SCS

    Page :175-176

    Z.Y. Song, C. Ultenius, G. Schechtmann, B.A. Meyerson, B. Linderoth

    
• • ·397 Effects of traumatic and selective chemical lesions of peripheral nerves on TRPV1 receptor expression: Implications for vanilloid-induced analgesia

    Page :176

    C. Szigeti, E. Kortvely, P. Santha, T. Nyari, K. Gulya, G. Jancso

    
• • ·398 Is up-regulation of neurosteroid synthesis important for the maintenance of neuropathic pain?

    Page :176-177

    T. Tanabe, D. Kondo, R. Yabe, I. Takasaki, T. Kurihara, H. Saegusa, S. Zong

    
• • ·399 Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain

    Page :177

    N. Ueceyler, A. Tscharke, C. Sommer

    
• • ·400 Direct inhibitory effects of gabapentin on spinal mechanosensory neurons following peripheral neuropathy in the rat

    Page :177

    K.-C. Choong, A. Liang, M.O. Urban

    
• • ·401 Perineural HIV-1 gp120 is associated with reduced intraepidermal nerve fibre density and altered sensory neurone phenotype

    Page :178

    V.C.J. Wallace, A.R. Segerdahl, J. Blackbeard, S.B. McMahon, A.S.C. Rice

    
• • ·402 Dynamic responses of deep spinal dorsal horn nociceptive-specific neurons to persistent nociception

    Page :178-179

    H.J. You, F.C. Colpaert, L. Arendt-Nielsen

    
• • ·403 Effects of a novel P2X3/P2X2/3 antagonist RO-4 on cold and mechanical allodynia in two rat neuropathic pain models

    Page :179

    Q.-M. Zhu, P.A. Nunn, D.Q. Hu, M.F. Jett, D.A. Cockayne, M.P. Dillon, A.P.D.W. Ford

    
• • ·404 Neurolitic epidural block with 5% phenol in cancer patients

    Page :179

    A.R. Bameshki, S. Jahanbakhsh

    
• • ·405 Long-term results of the microsurgical Drez-tomy for neuropathic pain due to brachial plexus avulsion: Clinical learning about pain mechanism

    Page :179-180

    E. Blondet, M. Sindou

    
• • ·406 Precision rechargeable spinal cord stimulation (SCS) system: Programming parameters and battery longevity

    Page :180

    K. Bradley, A.C. Khodavirdi

    
• • ·407 Sympathetic block treatment for RSD in children

    Page :180-181

    J.M. Currie

     
• • ·408 Nerve blocks can interrupt axonal reflex and avoid persistent pain to translate into chronic and neurophatic pain

    Page :181

    L. Di Lorenzo, C. Di Maria, A.M. Forte, C. Trombetti, A. Bello, V. Palmieri, V. Saviano, E. Di Blasio

     
• • ·409 Minimally invasive epidural stimulation under local anaesthesia in the treatment of neuropathic pain

    Page :181-182

    M.C. Djian, G. Abi Lahoud, P. Page, F.X. Roux

    
• • ·410 Spinal flexometer: Measurements that potentially reflect changes in pain

    Page :182

    S.G. Eidelson, J.C. Wilkerson, J. Fleming, S. Eidelson

     
• • ·411 Health-related quality of life in chronic neuropathic pain patients: Results of the process study

    Page :182-183

    S. Eldabe

    
• • ·412 Dysaesthesic pain and burning skin sensations as adverse effects to spinal cord stimulator implantation for treatment of angina pectoris

    Page :183

    T.P. Enggaard, C. Scherer, C. Andersen

    
• • ·413 Motor cortex stimulation for complex regional pain syndrome (CRPS type I) results in pain relief and functional recovery

    Page :183

    E.T. Fonoff, M.J. Teixeira, T.Y. Lin, M.A. Marcolin

    
• • ·414 The utility of zero-volt battery technology when battery charge is depleted

    Page :183-184

    A. Foster, G. Arcos, S. Kramarich

    
• • ·415 Neuropathic pain in dentistry: Three case reports

    Page :184

    M.R. Fussnegger

    
• • ·416 Pain syndrome treatment in vertebrogen radiculopathy with very high frequency millimetric waves

    Page :184-185

    M.T. Ganea, S.A. Groppa, A. Hangan, S. Scripcaru

    
• • ·417 Pain management of low back pain in a district hospital

    Page :185

    E. Kapota, C. Savvidou, I. Serpetinis, I. Lykoudi, L. Baltatzi, A. Kouta

    
• • ·418 Successful control of back and leg pain with a next generation spinal cord stimulation (SCS) device following initial treatment failure

    Page :185-186

    A.C. Khodavirdi, J.M. Epstein, S.B. Khan, R.M. Rosenthal, A. Foster

    
• • ·419 Effect of monochromatic near infrared energy on neuropathy, plantar pressure distribution and balance in patients with diabetic neuropathy

    Page :186

    S.P Madani, N. Lessan, M. Akbari, S. Amirimoghaddam, R. Heshmat, B. Larijani

    
• • ·420 Development and implementation of an interdisciplinary pain course

    Page :186-187

    E.L. Manning, H. Martin, J. Baisden, A. Smith

    
• • ·421 Effects of slow repetitive transcranial magnetic stimulation (TMS) on complex regional pain syndrome (CRPS)

    Page :187

    N.C. Moore, P. MacMillan, M Cooper

    
• • ·422 Pulsed radiofrequency treatment (PRF) with Pasha Cath in neuropatic pain

    Page :187

    A. Orlando, G. Sindaco, L. Ravaioli, L. Follini, G. Pari

    
• • ·423 Multicentric trial for the assessment of analgesic effectiveness of pulsed radiofrequency treatment (PRF) with Pasha Cath in lumbosacral monoradiculopathy

    Page :187-188

    G. Pari, L. Follini, G. Orlandini, A. Orlando, G. Sindaco

    
• • ·424 Repetitive transcranial magnetic stimulation over the motor cortex can change the pain perception in patients with complex regional pain syndrome

    Page :188

    H. Picarelli, M.J. Teixeira, M.A. Marcolin, M.L. Myczkowski, T.B. Luvisotto

    
• • ·425 Clinical experience with a new rechargeable stimulation device for spinal cord stimulation – A two years follow-up

    Page :188-189

    D. Rasche, D. Klase, V.M. Tronnier

    
• • ·426 Use of methadone for pain treatment and prolonged sedation in critically ill patients

    Page :189

    D. Robert, B. Dekeyser, H. Demey, M. Van Utterbeeck, G. Hans

    
• • ·427 One of the causes of buttock and numbness of lower extrimities

    Page :189

    K. Sato, R. Mito, S. Sato, Y. Kumada, K. Sato, T. Kawamura

    
• • ·428 Does tens have an effect on neuropathic pain? A pilot study in MS

    Page :189-190

    F. Schyns, F. Coutts

    
• • ·429 Drez operation in brachial plexus pain: Long term results

    Page :190

    B. Silhouette, A. Margot-Duclot, H. Andrianasolo, L. Sitzmann, J.B. Thiebaut

    
• • ·430 Epidural adhesiolysis and pulsed radiofrequency treatment (PRF) with Pasha Cath vs adhesiolysis with Racz catheter

    Page :190-191

    G. Sindaco, A. Orlando, L. Ravaioli, L. Follini, G. Pari

    
• • ·431 Spinal cord stimulation in allodynic spinal cord injury (SCI) pain

    Page :191

    L. Sitzmann, B. Silhouette, A. Margot-Duclot, H. Andrianasolo, J.B. Thiebaut

    
• • ·432 Chronic management of total implantable pumps for pain treatment: Review of personal experience and observations

    Page :191-192

    N. Stefani, G. Rea, D. Mangeruga, P.V. Nardi

    
• • ·433 Cost effectiveness of spinal cord stimulation for neuropathic pain: A european survey on quality of life and healthcare resource utilisation

    Page :192

    R.S. Taylor, R.J. Taylor

    
• • ·434 Prediction of results of motor cortex stimulation in treatment of brachial plexus avulsion pain by transcranial magnetic stimulation

    Page :192

    M.J. Teixeira, E.T. Fonoff, F. Macri, H. Picarelli, T.Y. Lin, M.A. Marcolin

    
• • ·435 Topical essential oils for fibromyalgia neuropathic pain: A randomized controlled trial

    Page :192-193

    G. Traitses, A. Hum, G.D. Ko, D. Berbrayer

    
• • ·436 Application of stellate ganglion block for the treatment of neuropathic head, neck, arm and chest pain

    Page :193

    A. Vaitkus

    
• • ·437 Prospective outcomes study on the Restore^® rechargeable neurostimulation system for neuropathic pain: A multi-center study

    Page :193-194

    J.P. Van Buyten, Y. Lazorthes, G.H. Spincemaille, V. Tronnier, G. Beute, J.J. Pallares, H. Naous, F. Zucco, J.K. Krauss, J.A. De Andres

    
• • ·438 Pulsed radiofrequency (PRF) for the treatment of occipital neuralgia: A clinical audit

    Page :194

    P. Vanelderen, M. Puylaert, P. De Vooght, J. Sterken, R. Heylen, J. Van Zundert

    
• • ·439 TENS in neuropathic and nociceptive pain

    Page :194-195

    T. Vemmer

    
• • ·440 Opioids and theiŕs position in the treatment failed back surgery syndrome

    Page :195

    I. Vrba, J. Kozák, I. Stetkárová

    
• • ·441 Comparing the efficacy of thoracic transforaminal injection of magnesium versus intercostal nerve block with methylprednisolone for chronic post thoracotomy pain syndrome

    Page :195-196

    M. Yosry

    
• • ·442 Wide-dynamic range neurons sensitization and spinal manipulative therapy: A rationale for osteopathic management of neuropathic pain?

    Page :196

    R. Zegarra-Parodi

    
• • ·443 Involvement of spinal astrocytes and glutamate transport GLT-1 in processing tetanically sciatic stimulation-induced mechanical allodynia in rat

    Page :196-197

    Z.-Y. Wang, N. Lu, Y.-Q. Zhang, Z.-Q. Zhao

    
• • ·444 Neurophysiological characterization of postherniorrhaphy pain

    Page :197

    E.K. Aasvang, B. Brandsborg, B. Christensen, T.S. Jensen, H. Kehlet

    
• • ·445 Temporal Summation of pain – Reproducibility in normal volunteers

    Page :197

    A. Bet, J. Acosta-Guillen, R. Lecybyl, M. Hanna

    
• • ·446 A prospective study of pain after hysterectomy in women with benign uterine disorders

    Page :197-198

    B. Brandsborg, M. Dueholm, L. Nikolajsen, L. de Lasson, H. Kehlet, T.S. Jensen

    
• • ·447 Hyperalgesic and allodynic effects of nocebo suggestions

    Page :198

    L. Colloca, S. Vighetti, M. Sigaudo, F. Benedetti

    
• • ·448 Effect of tramadol on laser evoked potentials in humans: Preliminary results

    Page :198-199

    F. Galeotti, A. Truini, A. Albanese, M.R. Maluccio, F. Sartucci, G. Cruccu

    
• • ·449 Microvascular decompression (MVD) in trigeminal neuralgia (TN) treatment

    Page :199

    Yu.A. Shulev, K.S. Gordienko

    
• • ·450 Pain, anxiety and depression in neuropathic and non-neuropathic pain patients compared with healthy controls. A quantitative study

    Page :199-200

    L. Gormsen, R. Rosenberg, F.W. Bach, T.S. Jensen

    
• • ·451 Spatial and temporal stimulus parameters of conditioning stimulation affect the magnitude and direction of human pain plasticity

    Page :200

    R.M. Gracien, W. Magerl, T. Klein, R.-D. Treede

    
• • ·452 Inhibition of cortical laser evoked potentials by transcutaneous electrical nerve stimulation

    Page :200

    G. Jonker, C.F. Van Swol, D. Brandsma, E.H. Boezeman, H.P.A. Van Dongen, H.J.A. Nijhuis

    
• • ·453 HIV-positive outpatients on antiretroviral therapy have the same pain intensity but greater risk of neuropathic pain than treatment naïve patients

    Page :201

    P.R. Kamerman, D. Mitchell, N.R. Mphahlele

    
• • ·454 Somatosensory perception threshold alterations do not predict the presence of pain in peripheral nerve injury. Preliminary results

    Page :201

    A.H. Landerholm, P.T. Hansson

    
• • ·455 Reproducibility of pain desensitization produced by continuous 2 Hz electric stimulation

    Page :201-202

    R. Lecybyl, J. Ghoshdastidar, A. Bet, M. Hanna

    
• • ·456 Somatosensory processing in PINK1 (PARK6) and PARKIN mutation carriers: Its potential role in Parkinson’s disease

    Page :202

    J. Ludwig, F. Lienau, R. Maag, J.M. Hagenah, G. Deuschl, E. Fritzer, C. Klein, R. Baron, C. Helmchen

    
• • ·457 Systematic review of the prevalence of neuropathic pain

    Page :202-203

    A. Mailis Gagnon, A. Furlan, S.F. Lakha, B. Yegneswaran

    
• • ·458 Results from TRPM8 and TRPA1 activation through menthol and cinnamaldehyde in patients with cold allodynia following cold injury

    Page :203

    B. Namer, I.P. Kleggetvait, E. Jorum

    
• • ·459 Low back pain and neuropathic pain in Iranian nurses

    Page :203

    S.H. Pedram, J. Moradi

    
• • ·460 Comparison of evoked potentials in response to painful stimulations delivered by YAP or CO₂ laser

    Page :204

    C. Perchet, M. Magnin, M. Frot, V. Legrain, L. Garcia-Larrea

    
• • ·461 Homotopic stimulation can reduce the area of allodynia in patients with neuropathic pain

    Page :204

    M. Besson, S.J. Love-Jones, C.E. Steeds, P. Brook, B.A. Chizh, A.E. Pickering

    
• • ·462 Topical menthol: Stability of a sensory profile in a human surrogate model

    Page :204-205

    M. Stengel, A. Binder, O. Klebe, G. Wasner, J. Schattschneider, R. Baron

    
• • ·463 S100 beta in pain

    Page :205

    D. Tammaro, D. Da Prato, B. Battista, M. Spano, R. Melillo, D. Faticato, R. Palomba

    
• • ·464 Neuropathic pain is common, disabling, and greatly impairs quality of life and earning potential in Canadians: A population-based survey

    Page :205-206

    C. Toth, J. Lander

    
• • ·465 Pathophysiology of neuropathic pain in carpal tunnel syndrome: A clinical and neurophysiological study – Preliminary results

    Page :206

    A. Truini, F. Galeotti, M. Virtuoso, M. Inghilleri, L. Padua, G. Cruccu

    
• • ·466 A randomized sham-controlled trial of mirror therapy for lower limb phantom pain demonstrates efficacy of mirror therapy

    Page :206-207

    P.J.W. Tsao, B.L. Chan, R. Witt, R. Howard, A. Charrow, A. McGee, P.F. Pasquina, K.M. Heilman

    
• • ·467 Persistent pain after cardiac surgery: A neuropathic problem?

    Page :207

    J. Watt-Watson, B. Stevens, J. Costello, M. McGillion

    
• • ·468 Correlations between clinical neuropathic pain responses and experimental pain measures in postamputation pain

    Page :207-208

    C.H. Wilder-Smith, L. Hill

    
• • ·469 Contact heat evoked potentials and spinothalamic tract conduction velocity determination

    Page :208-209

    S. Wydenkeller, V. Dietz, A. Curt, P. Halder

    
• • ·Author Index

    Page :209-216